BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 34856364)

  • 21. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Long-Read Sequencing Analysis Discloses the Transcriptome Features of Papillary Thyroid Microcarcinoma.
    Wang Y; Zou B; Zhang Y; Zhang J; Li S; Yu B; An Z; Li L; Cui S; Zhang Y; Yao J; Shi X; Liu J
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1263-1274. PubMed ID: 38038628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis.
    Chi Q; Geng X; Xu K; Wang C; Zhao H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
    Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
    Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.
    Li M; Zhang J; Zhang Z; Qian Y; Qu W; Jiang Z; Zhao B
    Front Endocrinol (Lausanne); 2022; 13():721569. PubMed ID: 35185791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.
    Liang W; Sun F
    J Endocrinol Invest; 2018 Oct; 41(10):1237-1245. PubMed ID: 29520684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome Analysis Identified 2 New lncRNAs Associated with the Metastasis of Papillary Thyroid Carcinoma.
    He S; Arikin A; Chen J; Huang T; Wu Z; Wang L; Yang F; Li Y; Yang Y; Wang R; Lian M; Zhong Q; Fang J
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(3):247-254. PubMed ID: 34818244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.
    Song Y; Fu LJ; Li HT; Qiu XG
    Sci Rep; 2019 Apr; 9(1):5800. PubMed ID: 30967566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF Status in Papillary Microcarcinomas of the Thyroid Gland: a Brief Review.
    Ieni A; Vita R; Cardia R; Giuffré G; Benvenga S; Tuccari G
    Curr Mol Med; 2019; 19(9):665-672. PubMed ID: 31625469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
    Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
    [No Abstract]   [Full Text] [Related]  

  • 33. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
    Xu Q; Song A; Xie Q
    Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration and validation of hub genes and pathways in the progression of hypoplastic left heart syndrome via weighted gene co-expression network analysis.
    Liu X; Shang H; Li B; Zhao L; Hua Y; Wu K; Hu M; Fan T
    BMC Cardiovasc Disord; 2021 Jun; 21(1):300. PubMed ID: 34130651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
    Qu T; Li YP; Li XH; Chen Y
    Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
    Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
    Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
    Bansal R; Saxena U
    Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma.
    Feng Z; Song Y; Qian J; Chen T; Yang C; Jia L; Liu C; Liu P; Lv J; Deng Z
    Ann Endocrinol (Paris); 2019 Apr; 80(2):77-83. PubMed ID: 30685058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.